RAPGEF3 and prostate cancer: Another mechanism by which Epac stimulates prostate cancer cells proliferation is by Rap1-mediated increase in the level of cell cycle regulators, such as cyclin B1 and CDK1, which play a role in the transition of cells from G2 to M phase and promote mitogenesis [64].